CEMI Chembio Diagnostics Inc

Chembio Diagnostics Inc develops, manufacture markets & licenses rapid point of care diagnostic tests that detect infectious diseases. Its products are rapid tests for the detection of HIV 1/2 antibodies, & for the detection of HIV & Syphilis antibodies.

As of 07/23/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  06/07/2012
Outstanding shares:  20,244,554
Average volume:  30,411,972
Market cap:   $87,254,028
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    163572209
ISIN:        US1635722093
Sedol:      B80H073
Valuation   (See tab for details)
PE ratio:   -2.48
PB ratio:   2.66
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy